Guizhounli Pharmaceutical Co (SHSE:603439) Cyclically Adjusted Book per Share: ¥2.73 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603439 Guizhou Sanli Pharmaceutical Co Ltd SHSE:603439
85 GF Score
Price ¥10.01
GF Value ¥15.07
Valuation Significantly Undervalued
! 10 Warning Signs
View Full Analysis

What is Guizhounli Pharmaceutical Co Cyclically Adjusted Book per Share?

Guizhounli Pharmaceutical Co SHSE:603439 +3.41% 85 Cyclically Adjusted Book per Share is ¥2.73 as of Mar. 2026. GuruFocus rates SHSE:603439 with a GF Score™ of 85/100 and a GF Value™ of ¥15.07 (Significantly Undervalued). The stock has 10 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Guizhounli Pharmaceutical Co's adjusted book value per share for the three months ended in Mar. 2026 was ¥3.652. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥2.73 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-27), Guizhounli Pharmaceutical Co's current stock price is ¥10.01. Guizhounli Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was ¥2.73. Guizhounli Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is 3.67.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Guizhounli Pharmaceutical Co was 6.23. The lowest was 3.55. And the median was 4.50.


Guizhounli Pharmaceutical Co  (SHSE:603439) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Guizhounli Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=10.01/2.73
=3.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Guizhounli Pharmaceutical Co was 6.23. The lowest was 3.55. And the median was 4.50.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Guizhounli Pharmaceutical Co Cyclically Adjusted Book per Share Related Terms


Guizhounli Pharmaceutical Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Guizhounli Pharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guizhounli Pharmaceutical Co Cyclically Adjusted Book per Share Chart

Guizhounli Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 2.63

Guizhounli Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 2.63 2.73

SHSE:603439 vs ZTS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Guizhounli Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guizhounli Pharmaceutical Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Guizhounli Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Guizhounli Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


SHSE:603439
85GF Score
Guizhou Sanli Pharmaceutical Co Ltd SHSE:603439
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guizhounli Pharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Guizhounli Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=3.652/116.3033*116.3033
=3.652

Current CPI (Mar. 2026) = 116.3033.

Guizhounli Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201412 0.850 99.000 0.999
201506 1.465 99.500 1.712
201512 1.689 100.600 1.953
201606 1.955 101.400 2.242
201612 3.359 102.600 3.808
201703 0.000 103.200 0.000
201706 3.204 103.100 3.614
201712 1.291 104.500 1.437
201803 1.176 105.300 1.299
201806 1.255 104.900 1.391
201812 1.413 106.500 1.543
201903 0.000 107.700 0.000
201906 1.563 107.700 1.688
201909 0.000 109.800 0.000
201912 1.776 111.200 1.858
202003 1.662 112.300 1.721
202006 2.295 110.400 2.418
202009 2.299 111.700 2.394
202012 2.411 111.500 2.515
202103 2.468 112.662 2.548
202106 2.331 111.769 2.426
202109 2.414 112.215 2.502
202112 2.510 113.108 2.581
202203 2.569 114.335 2.613
202206 2.677 114.558 2.718
202209 2.779 115.339 2.802
202212 3.016 115.116 3.047
202303 3.161 115.116 3.194
202306 3.191 114.558 3.240
202309 3.329 115.339 3.357
202312 3.587 114.781 3.635
202403 3.757 115.227 3.792
202406 3.722 114.781 3.771
202409 3.911 115.785 3.929
202412 3.727 114.893 3.773
202503 3.838 115.116 3.878
202506 3.611 114.907 3.655
202509 3.621 115.471 3.647
202512 3.535 115.832 3.549
202603 3.652 116.303 3.652

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ¥2.73 mean?
Guizhounli Pharmaceutical Co (SHSE:603439) has a Cyclically Adjusted Book per Share of ¥2.73 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Guizhounli Pharmaceutical Co and its competitors.
Is Guizhounli Pharmaceutical Co's Cyclically Adjusted Book per Share too high?
Guizhounli Pharmaceutical Co's current Cyclically Adjusted Book per Share is ¥2.73. Overall, Guizhounli Pharmaceutical Co has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Guizhounli Pharmaceutical Co's Cyclically Adjusted Book per Share compare to ZTS?
Guizhounli Pharmaceutical Co's Cyclically Adjusted Book per Share of ¥2.73 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Guizhounli Pharmaceutical Co and its competitors. Guizhounli Pharmaceutical Co's current Cyclically Adjusted Book per Share is ¥2.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guizhounli Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Guizhounli Pharmaceutical Co (SHSE:603439) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥15.07, compared to a current price of ¥10.01 — trading 33.6% below its estimated fair value. The current Cyclically Adjusted Book per Share is ¥2.73. Guizhounli Pharmaceutical Co's overall GF Score™ is 85/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Guizhounli Pharmaceutical Co (SHSE:603439), the current Cyclically Adjusted Book per Share is ¥2.73 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guizhounli Pharmaceutical Co (SHSE:603439) Overvalued in 2026?

Based on GuruFocus' analysis, Guizhounli Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥10.01 is trading 33.6% below its estimated GF Value™ of ¥15.07. GuruFocus considers Guizhounli Pharmaceutical Co to be Significantly Undervalued.

Key valuation signals for SHSE:603439:

  • Cyclically Adjusted Book per Share: ¥2.73
  • GF Value™: ¥15.07 vs. price of ¥10.01 (33.6% below fair value)
  • GF Score™: 85/100 with 10 warning signs

No single metric tells the full story. See the SHSE:603439 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Guizhounli Pharmaceutical Co Business Description

Address Xiayun Industrial Park, Pingba District, Guizhou Province, Anshun, CHN, 561000
Guizhou Sanli Pharmaceutical Co Ltd is engaged in Chinese pharmaceutical research, development, production and marketing. The company produces and sells soft capsules, hard capsules, sprays (including Chinese medicine extraction) and provides Chinese medicine science and technology consulting services. Its products include Pediatric medication; Respiratory system medication; Cardiovascular and cerebrovascular drugs; Digestive medicine; Trauma injury medication; Rehabilitation medicine; and Ophthalmic medicine.
85GF Score

Get the complete analysis for SHSE:603439

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥10.01
Price
¥15.07
GF Value